21.11.2017
- Boehringer Ingelheim has been granted its first biosimilar approval in Europe, receiving authorization to market Cyltezo for treating a variety of chronic inflammatory diseases in...
03.10.2017
- Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...
27.09.2017
- Investigation into future trends in the medical and pharmaceutical sector shows that digitalization is changing supply chains in the healthcare industry. Such diverse issues like...
27.09.2017
- Pharma Waldhof is active in the development and commercialization of active substances, key intermediates and reagents for multiple applications in the pharmaceutical, diagnostics...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
03.05.2017
- Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...
28.04.2017
- German pharmaceuticals and chemicals producer Merck is divesting its Biosimilars business to compatriot firm Fresenius Kabi, a unit of medical technology and healthcare group...
